EXHIBIT 10.54
Letter of Intent "LOI"
Between
Imaging Diagnostic Systems, Inc. "IMDS"
0000 XX 00xx Xxxxx
Xxxxxxxxxx, Xxxxxxx 00000
Represented by: Xxxxx X. Xxxxxx
And
Sanotech Group Srl. "STG"
28 bis General Budisteanu,
Bucharest, Xxxxxxx, Xxxxxx 0
Represented by: Xxxxx X. Xxxx III
Bucharest, 8 January 2002
It is hereby agreed by the above parties to cooperate together in order
to introduce IMDS products into the "Territories" (indicated below) for the
purpose of presenting the technology to the market and for the sale of the IMDS
CTLM(R) Systems "CTLM(R)". STG agrees to meet the "Vienna Milestones" and
"Bucharest Milestones" on a timely basis. IMDS agrees to grant "Warrants" to STG
in exchange for deliverables stipulated under this LOI. Sales commissions in
favor of STG will be agreed upon between the parties on a case by case basis.
IMDS agrees to proved STG with an implementation budget upon request for the
following:
Vienna Milestones:
Vienna - - Homologation and authorizations: up to USD $25,000
- Marketing and promotional events:up to USD $25,000
Bucharest Milestones:
Bucharest - Homologation and authorizations: up to USD $15,000
- Marketing and promotional events:up to USD $25,000
STG will draw down against the implementation budget as required and
will provide IMDS with the requisite invoices prior to draw down. IMDS agrees to
settle the said invoices within 5 banking days from receipt.
IMDS agrees to provide two complete CTLM(R) Systems and to deliver them
at its own cost to Vienna and Bucharest site hospitals, free of charge to STG,
no later than 15 March, 2002. It is also agreed that IMDS will train the
necessary doctors/service engineers at IMDS's facility in Plantation, Florida
USA.
IMDS will install the two CTLM(R) Systems at no charge to STG.
IMDS will provide two weeks training for the Clinical Applications
Specialists at each individual site.
The parties must mutually agree upon the content and timing for all
press releases associated with the proposed transactions and related services.
The parties must agree that a moratorium will be placed on all agency
representation and distribution agreements in Europe, Central Europe and Eastern
Europe, until 90 days following the installation and training of the respective
doctors on the second CTLM(R) ("Initial Period").
Upon successful completion of the Vienna and Bucharest Milestones within the
Initial Period, STG shall have a right of first refusal on the exclusive
representation rights fro the regions mentioned above, for an additional 90 days
("Follow UP Period"). To that end, we wish to discuss any distribution
agreements which may currently exist and would like the opportunity to replace
any existing distributors as soon as practicably possible. However, during the
Initial Period and Follow Up Period, IMDS shall maintain the right to sell the
CTLM(R) directly to end users who have been in contact prior to or during the
Initial Period or Follow Up Period.
"Warrants" shall be defined as cashless Warrants to purchase 1,500,000
shares of IMDS common stock "Stock" pursuant to the terms an conditions as set
forth below in "EXHIBIT A". IMDS further agrees that upon the execution of each
Milestone, it shall file a registration statement covering the underlying Stock
with U.S. Securities and Exchange Commissions, via
Form S-8. The Warrants shall have an exercise price equal to 125% of the market
price upon execution of each Milestone.
EXHIBIT A
Vienna:
62,500 shares - Upon arrival and acceptance of the CTLM(R) from Florida to
Vienna on temporary import basis (title to the systems to remain in the name of
IMDS).
62,500 shares - Upon installation and training at AKH hospital.
62,500 shares - Upon homologation and authorization from the Austrian Ministry
of Health and Hospital Administration.
62,500 shares - Upon completion of the marketing and promotional events
(exclusive of ECR)
Bucharest:
62,500 shares - Upon arrival and acceptance of the CTLM(R) from Florida to
Bucharest.
62,500 shares - Upon installation and training at Colentina Hospital.
62,500 shares - Upon homologation and authorization from Ministry of Health,
National Assurance House and the Hospital Authorities.
62,500 shares - Upon completion of the marketing and promotional events,
together with a national public awareness campaign in connection with the
Romanian First Lady's breast cancer program.
200,000 shares - Upon the 5th CTLM(R) sold through the auspices of STG.
200,000 shares - Upon the 10th CTLM(R) sold through the auspices of STG.
300,000 shares - Upon the 20th CTLM(R) sold through the auspices of STG.
300,000 shares - Upon the 40th CTLM(R) sold through the auspices of STG.
This LOI shall be governed in accordance with the rules of the American
Arbitration Association, in the jurisdiction of the County of New York, New
York, USA.
The parties agree to conclude a final and definitive Cooperation
Agreement "Cooperation Agreement" with 30 days from the date of this LOI. This
LOI will remain in force for a period of twelve months or until the Cooperation
Agreement is executed, and shall be included as an integral part of the said
Cooperation Agreement.
2
"Territories" shall be defined as the national sovereignties of Austria and
Romania.
"Vienna Milestones" shall be defined as a prestigious hospital location for
installation of the CTLM(R) in Vienna. Homologation and authorization approvals
from the Austrian Ministry of Health and Hospital Administration from AKH
Hospital Vienna. Marketing and promotional events (exclusive of ECR).
Symposiums, congresses and a public awareness campaign. Promotional activities
to take place over a period of 90-180 days. STG will cover all cost associated
with the operation of the system in AKH Hospital.
"Bucharest Milestones" shall be defined as the homologation and authorization
from the Ministry of Health , National Assurance House, (if required) together
with Colentina Hospital Bucharest Administration Authorities. Marketing and
promotional events, together with national public awareness campaign in
connection with the Romanian First Lady's breast cancer program over a period of
90-180 days. STG will cover all cost associated with the operation of the system
in Colentina Hospital.
[END]
This Letter of Intent is agreed this day 8, January 2002 and is signed in four
(4) originals.
For and on Behalf of Imaging Diagnostic Systems, Inc.
/s/ Xxxxx X. Xxxxxx
--------------------------------
By: Xxxxx X. Xxxxxx, CEO
For and on Behalf of Sanotech Group Srl.
/s/ Xxxxx X. Xxxx
---------------------------
By Xxxxx X. Xxxx, Director
3
